Use of proton pump inhibitors may cause squamous epithelial masking of intramucosal carcinoma in Barrett's esophagus.
Tanaka
K
K
Department of Endoscopic Medicine, Mie University School of Medicine, Tsu, Japan.
Toyoda
H
H
Kadowaki
S
S
Hamada
Y
Y
Kosaka
R
R
Yamanaka
M
M
Imoto
I
I
D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000009:adverse effects* / Q000627:therapeutic use; D000230:Adenocarcinoma / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D000368:Aged; D001471:Barrett Esophagus / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D001706:Biopsy; D003951:Diagnostic Errors; D004848:Epithelium / Q000187:drug effects* / Q000473:pathology; D004938:Esophageal Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D004942:Esophagitis, Peptic / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D004945:Esophagoscopy; D004947:Esophagus / Q000187:drug effects / Q000473:pathology / Q000601:surgery; D006801:Humans; D008297:Male; D009092:Mucous Membrane / Q000473:pathology / Q000601:surgery; D054328:Proton Pump Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D064750:Rabeprazole
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D054328:Proton Pump Inhibitors; D064750:Rabeprazole